Crescendo Biologics appoints Matthew Roe CBO
This article was originally published in Scrip
Executive Summary
Crescendo Biologics, a company developing antibody therapies, has appointed Matthew Roe chief business officer. Mr Roe most recently served as senior director of business development and licensing for Genzyme, where he was employed for 23 years from the firm's start-up.